References: |
Bhoumik, A., Jones, N. and Ronai, Z. "Transcriptional switch by activating transcription factor 2-derived peptide sensitizes melanoma cells to apoptosis and inhibits their tumorigenicity," Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4222 - 4227. Gutpa, S., Campbell, D., Derijard, B. and Davis, R. "Transcription factor ATF2 regulation by the JNK signal transduction pathway," Science 267 (1995) 389 - 393. Ivanov, V.N., Bhoumik, A. and Ronai, Z. "Death receptors and melanoma resistance to apoptosis," Oncogene 22 (2003) 3152 - 3161. Karin, M. and Hunter, T. "Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus," Curr. Biol. 5 (1995) 747 - 757. Laifenfeld, D., Karry, R., Grauer, E., Klein, E. and Ben-Shachar, D. "ATF2, a member of the CREB/ATF family of transcription factors, in chronicstress and consequent to antidepressant treatment: animal models and humanpost-mortem brains," Neuropsychopharmacology 29 (2004) 589 - 97. Maekawa, T., Sakura, H., Kanei-Ishii, C., Sudo, T., Yoshimura, T. and Fujisawa, J. "Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain," EMBO J. 8 (1989) 2023 - 2028. |